BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31552620)

  • 1. Validation of the Brandwein Gensler Risk Model in Patients of Oral Cavity Squamous Cell Carcinoma in North India.
    Chaturvedi A; Husain N; Misra S; Kumar V; Gupta S; Akhtar N; Lakshmanan M; Garg S; Arora A; Jain K
    Head Neck Pathol; 2020 Sep; 14(3):616-622. PubMed ID: 31552620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological risk score and its role in predicting recurrence in early-stage oral squamous cell carcinomas.
    Fonseca D; Khemani R; Pasam MK; Tagore R; Rao BV; Kodandapani S; Rao C; V N Raju KV; Rao TS
    Indian J Pathol Microbiol; 2023; 66(3):444-448. PubMed ID: 37530322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.
    Jerjes W; Upile T; Petrie A; Riskalla A; Hamdoon Z; Vourvachis M; Karavidas K; Jay A; Sandison A; Thomas GJ; Kalavrezos N; Hopper C
    Head Neck Oncol; 2010 Apr; 2():9. PubMed ID: 20406474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reframing Histological Risk Assessment of Oral Squamous Cell Carcinoma in the Era of UICC 8th Edition TNM Staging.
    Rahman N; MacNeill M; Wallace W; Conn B
    Head Neck Pathol; 2021 Mar; 15(1):202-211. PubMed ID: 32661668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma.
    Li Y; Bai S; Carroll W; Dayan D; Dort JC; Heller K; Jour G; Lau H; Penner C; Prystowsky M; Rosenthal E; Schlecht NF; Smith RV; Urken M; Vered M; Wang B; Wenig B; Negassa A; Brandwein-Gensler M
    Head Neck Pathol; 2013 Sep; 7(3):211-23. PubMed ID: 23250819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-host interface in oral squamous cell carcinoma: Impact on nodal metastasis and prognosis.
    Thakur R; Thakar A; Malhotra RK; Sharma A; Kakkar A
    Eur Arch Otorhinolaryngol; 2021 Dec; 278(12):5029-5039. PubMed ID: 33743065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can High-Frequency Intraoral Ultrasound Predict Histological Risk Factors in Oral Squamous Cell Carcinoma? A Preliminary Experience.
    Caprioli S; Giordano GG; Pennacchi A; Campagnari V; Iandelli A; Parrinello G; Conforti C; Gili R; Giannini E; Marabotto E; Kayali S; Bianchi B; Peretti G; Cittadini G; Marchi F
    Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.
    Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):180-7. PubMed ID: 21232996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncological safety of submental island flap for reconstruction of pathologically node-negative and node-positive T1-2 oral squamous cell carcinoma-related defects: A retrospective study and comparison of outcomes.
    Wang J; Tan Y; Shen Y; Lv M; Li J; Sun J
    Oral Oncol; 2020 Mar; 102():104507. PubMed ID: 31896500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of recurrence amongst patients undergoing resection of oral squamous cell carcinoma with curative intent.
    Zubair F; Farooq S; Wright S; Schipani S; McMahon J
    Br J Oral Maxillofac Surg; 2022 Dec; 60(10):1379-1384. PubMed ID: 36266196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.
    Brandwein-Gensler M; Teixeira MS; Lewis CM; Lee B; Rolnitzky L; Hille JJ; Genden E; Urken ML; Wang BY
    Am J Surg Pathol; 2005 Feb; 29(2):167-78. PubMed ID: 15644773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for salvage surgery failure in oral cavity squamous cell carcinoma.
    Matsuura D; Valim TD; Kulcsar MAV; Pinto FR; Brandão LG; Cernea CR; Matos LL
    Laryngoscope; 2018 May; 128(5):1113-1119. PubMed ID: 28988428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
    Chow JCH; Cheuk W; Cho WCS; Wong CF; Au DWY; Tam AHP; Wong RCW; Chan JCH; Law SCC; Ngan RKC; Wong KH; Cheung KM
    JAMA Netw Open; 2023 Jul; 6(7):e2323890. PubMed ID: 37459093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Regional Recurrence and Salvage Treatment in Patients With Oral Cancer.
    Yosefof E; Hilly O; Stern S; Bachar G; Shpitzer T; Mizrachi A
    Laryngoscope; 2022 Apr; 132(4):786-792. PubMed ID: 34397102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of locoregional control in stage I/II oral squamous cell carcinoma classified by AJCC 8th edition.
    Subramaniam N; Balasubramanian D; Murthy S; Kumar N; Vidhyadharan S; Vijayan SN; Nambiar A; Thankappan K; Iyer S
    Eur J Surg Oncol; 2019 Nov; 45(11):2126-2130. PubMed ID: 31196702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 2 Trial of Chemoradiation Therapy Using Weekly Docetaxel for High-Risk Postoperative Oral Squamous Cell Carcinoma Patients.
    Li R; Jiang W; Dou S; Zhong L; Sun J; Zhang C; Zhu G
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):462-468. PubMed ID: 32126267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach.
    Carvalho AL; Magrin J; Kowalski LP
    Oral Dis; 2003 May; 9(3):112-8. PubMed ID: 12945592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of factors associated with the risk stratification of survivorship for stage IV squamous cell carcinoma of the oral cavity: A 10-year retrospective study.
    Cheng HC; Yang CC; Kao SY; Wu TY; Wu CH
    J Chin Med Assoc; 2020 May; 83(5):491-499. PubMed ID: 32132387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral lymph node recurrence rate and its prognostic factors in stage IVA-B well-lateralized oral cavity cancer.
    Chien JC; Hu YC; Chang KC; Huang YH; Huang CY; Kang BH; Liu WS
    Auris Nasus Larynx; 2021 Oct; 48(5):991-998. PubMed ID: 33526320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC.
    Grimm M
    Clin Transl Oncol; 2012 Nov; 14(11):870-80. PubMed ID: 22855158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.